Sterling Investment Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-7,228
Closed -$1.35M 64
2021
Q1
$1.35M Sell
7,228
-398
-5% -$77.9K 0.92% 37
2020
Q4
$1.29M Buy
7,626
+80
+1% +$11.9K 0.91% 36
2020
Q3
$1.12M Sell
7,546
-480
-6% -$74.3K 0.83% 37
2020
Q2
$1.32M Buy
8,026
+287
+4% +$44.1K 1.02% 33
2020
Q1
$1.07M Sell
7,739
-185
-2% -$25.4K 0.94% 33
2019
Q4
$1.04M Sell
7,924
-64
-0.8% -$7.42K 0.69% 39
2019
Q3
$893K Buy
7,988
+2,333
+41% +$260K 0.65% 37
2019
Q2
$627K Sell
5,655
-139
-2% -$16.4K 0.49% 45
2019
Q1
$752K Buy
+5,794
New +$705K 0.58% 41

Other funds holding LLY

Sterling Investment Management's LLY Position: Q2 2021 in Review

Sterling Investment Management sold out of Eli Lilly (LLY) in Q2 2021, closing a stake of 7,228 shares — an estimated $1.35M sold.

Sterling Investment Management first reported a position in LLY in Q1 2019 and held it in 9 quarters. The position peaked at $1.35M in Q1 2021. 2,021 funds tracked by Wall St. Rank hold LLY as of Q2 2021.

  • Sterling Investment Management reported no remaining Eli Lilly position as of Q2 2021 after selling out during the quarter.
  • Sterling Investment Management sold 7,228 Eli Lilly shares in Q2 2021, an estimated $1.35M.
  • Sterling Investment Management first reported a position in Eli Lilly in Q1 2019 and held it in 9 quarters.
  • Sterling Investment Management's Eli Lilly position peaked at $1.35M in Q1 2021.
  • 2,021 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2021.

Based on Sterling Investment Management's 13F filing for Q2 2021, filed 5 Aug 2021.